Clinical Trials
8
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
- Conditions
- Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2024-10-31
- Last Posted Date
- 2025-05-15
- Target Recruit Count
- 29
- Registration Number
- NCT06668558
- Locations
- 🇪🇸
University Hospital Son Espases, Palma de Mallorca, Baleares, Spain
🇪🇸Hospital Son Llatzer, Palma de Mallorca, Baleares, Spain
🇪🇸Institut Catala D oncologia Badalona, Badalona, Cataluña, Spain
Risk-adapted Therapy for Primary Acute Myeloid Leukemia
- Conditions
- Leukemia, Myeloid, Acute
- Interventions
- Procedure: Allogeneic matched or unrelated donor transplant.Procedure: Autologous peripheral blood stem cell transplantProcedure: Measurable residual disease
- First Posted Date
- 2020-12-29
- Last Posted Date
- 2023-06-27
- Target Recruit Count
- 1034
- Registration Number
- NCT04687098
- Locations
- 🇪🇸
ICO Badalona-Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸ICO Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain
🇪🇸Hospital Universitari Son Espases, Palma de Mallorca, Mallorca, Spain
Treatment of High Risk Myelodysplastic Syndromes (MDS) Not Candidates for Allogeneic Transplantation of Hematopoietic Progenitors (ALO-HSCT)
- Conditions
- Myelodysplastic Syndromes
- Interventions
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2020-10-26
- Target Recruit Count
- 150
- Registration Number
- NCT04602273
- Locations
- 🇪🇸
Son Llàtzer, Palma, Islas Baleares, Spain
Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML)
- Conditions
- Leukemia, Myelocytic, Acute
- Interventions
- Other: Autologous peripheral blood stem cell transplantation.Other: Allogeneic matched related or unrelated donor transplant.Other: CD34+ selection.Other: Mylotarg purging before autologous PBSC transplantation
- First Posted Date
- 2012-11-08
- Last Posted Date
- 2012-11-08
- Target Recruit Count
- 862
- Registration Number
- NCT01723657
- Locations
- 🇪🇸
Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸ICO Hospital Universitari de Bellvitge, L'Hospitalet del Llobregat, Barcelona, Spain
🇪🇸Hospital A Coruña, A Coruña, Coruña, Spain
Risk-adapted Therapy for Adult Acute Myeloid Leukemia.
- Conditions
- Leukemia, Myelocytic, Acute
- Interventions
- Other: Autologous transplantationOther: Allogeneic HLA-identical sibling transplantationOther: CD34+ selection
- First Posted Date
- 2012-10-30
- Last Posted Date
- 2012-11-01
- Target Recruit Count
- 354
- Registration Number
- NCT01716793
- Locations
- 🇪🇸
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸ICO Hospital Universitari de Bellvitge, L'Hospitalet del Llobregat, Barcelona, Spain
🇪🇸Hospital A Coruña, A Coruña, Coruña, Spain
- Prev
- 1
- 2
- Next